The incremental cost effectiveness of withdrawing pulmonary artery catheters from routine use in critical care

被引：18

作者：

Stevens K. ^{[1
,3
]}

McCabe C. ^{[1
]}

Jones C. ^{[2
]}

Ashcroft J. ^{[2
]}

Harvey S. ^{[2
]}

Rowan K. ^{[2
]}

机构：

[1] School of Health and Related Research (ScHARR), Health Economics and Decision Science, University of Sheffield, Sheffield

[2] Intensive Care National Audit and Research Centre (ICNARC), London

[3] School of Health and Related Research, Economics and Decision Science, University of Sheffield, Sheffield, S1 4DA, Regent Court

来源：

Applied Health Economics and Health Policy | 2005年 / 4卷 / 4期

关键词：

Economic Evaluation; Incremental Cost; Pulmonary Artery Catheter; Health Gain; Life Expectancy Table;

D O I：

10.2165/00148365-200504040-00008

中图分类号：

学科分类号：

摘要：

Objective: The objective of this study was to conduct an economic evaluation to identify any differences in the expected costs and outcomes between patients treated with pulmonary artery catheters (PACs) and those without, in order to better inform healthcare decision makers. Method: The evaluation was carried out alongside a clinical trial investigating the use of PACs in intensive care units (ICUs) in the UK. It was conducted from the perspective of the UK NHS, in which PACs are an established intervention. Treating patients without using a PAC was characterised as the new intervention. The primary outcome measure was QALYs. The secondary outcome measure was hospital mortality. NHS costs per patient were calculated for the financial year 2002/03. The bootstrap method was used to characterise the uncertainty of the results and to construct cost-effectiveness acceptability curves. Results: The cost per QALY and per life gained from the withdrawal of PACs were £2892 and £21 164, respectively. Conclusion: The results of this study indicate that withdrawal of PACs from routine clinical use in ICUs within the NHS would be considered cost effective in the current decision-making climate. © 2005 Adis Data Information BV. All rights reserved.

引用

页码：257 / 264

页数：7

共 35 条

[1]

Guyatt G., A randomized control trial of right-heart catheterization in critically ill patients: Ontario Intensive Care Study Group, J Intensive Care Med, 6, 2, pp. 91-95, (1991)

[2]

Rhodes A., Cusack R.J., Newman P.J., Et al., A randomised, controlled trial of the pulmonary artery catheter in critically ill patients, Intensive Care Med, 28, 3, pp. 256-264, (2002)

[3]

Richard C., Warszawski J., Anguel N., Et al., Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: A randomized controlled trial, JAMA, 290, 20, pp. 2713-2720, (2003)

[4]

Isaacson I.J., Lowdon J.D., Berry A.J., Et al., The value of pulmonary artery catheter and central venous monitoring in patients undergoing abdominal aortic reconstructive surgery: A comparative study of two selected, randomized groups, J Vasc Surg, 12, 6, pp. 754-760, (1990)

[5]

Joyce W., Provan J.L., Ameli F.M., Et al., The role of central haemodynamic monitoring in abdominal aortic surgery: A prospective randomised study, Eur J Vasc Surg, 4, 6, pp. 633-636, (1990)

[6]

Pearson K.S., Gomez M.N., Moyers J.R., Et al., A cost/benefit analysis of randomized invasive monitoring for patients undergoing cardiac surgery, Anesth Analg, 69, 3, pp. 336-341, (1989)

[7]

Bender J.S., Smith-Meek M.A., Jones C.E., Routine pulmonary artery catheterization does not reduce morbidity and mortality of elective vascular surgery, Ann Surg, 226, 3, pp. 229-237, (1997)

[8]

Berlauk J.F., Abrams J.H., Gilmour I.J., Et al., Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery: A prospective, randomized clinical trial, Ann Surg, 214, 3, pp. 289-299, (1991)

[9]

Sandham J.D., Hull R.D., Brant R.F., Et al., A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients, N Engl J Med, 348, 1, pp. 5-14, (2003)

[10]

Shoemaker W.C., Appel P.L., Kram H.B., Et al., Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients, Chest, 94, pp. 1176-1186, (1988)

← 1 2 3 4 →